News

Contact

48-49 Russell Square, London, WC1B 4JP UK

T: +44 (0)203 0084416

E: info@valirx.com

Upgrade hints at ValiRx's significant potential

The City broker Daniel Stewart has lifted its valuation on drug developer ValiRx following the recent acquis...

UPDATE - ValiRx sets up joint venture to advance lung cancer drug

---adds broker comment and share price--- ValiRx ( LON:VAL ) has set up a joint venture firm with Ta...

ValiRx sets up joint venture to advance lung cancer drug

ValiRx ( LON:VAL ) has set up a joint venture firm with Tangent Reprofiling Ltd to advance a treatment f...

ValiRx, e-Therapeutics, Oxford Pharmascience and Action Hotels to present next week

Next week's Proactive forum promises to be a dynamic evening as it showcases some of the most exciting non-r...

Q&A: ValiRx looks forward to clinical trials

Proactive Investors (PI) interviewed the management of the cancer drug treatment developer to find out about...

In the News

ValiRx Plc - In The News of The Telegraph, Business Club Section.

Please see below a link to a film on ValiRx plc (AIM: VAL) and interviews with its senior management, for your information:

Valirx plc is a life science company that focuses on cancer diagnostics and developing cancer therapeutics.
VIDEO LINK: http://www.telegraph.co.uk/finance/businessclub/business-club-video/technology-sector-videos/9328811/valirx.html#